Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9012 |
High Similarity |
NPD4076 |
Approved |
0.9012 |
High Similarity |
NPD4079 |
Approved |
0.8953 |
High Similarity |
NPD3505 |
Approved |
0.8953 |
High Similarity |
NPD3506 |
Approved |
0.8895 |
High Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.8547 |
High Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD3323 |
Discontinued |
0.8523 |
High Similarity |
NPD4181 |
Approved |
0.8514 |
High Similarity |
NPD5065 |
Approved |
0.8497 |
Intermediate Similarity |
NPD4640 |
Approved |
0.8497 |
Intermediate Similarity |
NPD4638 |
Approved |
0.8497 |
Intermediate Similarity |
NPD4639 |
Approved |
0.84 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.836 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.8352 |
Intermediate Similarity |
NPD8431 |
Approved |
0.8343 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.8324 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.8315 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.8295 |
Intermediate Similarity |
NPD3610 |
Approved |
0.8295 |
Intermediate Similarity |
NPD3609 |
Approved |
0.829 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.8251 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD1325 |
Approved |
0.8239 |
Intermediate Similarity |
NPD1326 |
Approved |
0.8202 |
Intermediate Similarity |
NPD4128 |
Approved |
0.8162 |
Intermediate Similarity |
NPD6281 |
Approved |
0.8156 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.8111 |
Intermediate Similarity |
NPD2144 |
Approved |
0.8105 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.8079 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD3038 |
Discontinued |
0.8045 |
Intermediate Similarity |
NPD4112 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD8110 |
Clinical (unspecified phase) |
0.7979 |
Intermediate Similarity |
NPD3404 |
Approved |
0.7978 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7957 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD1722 |
Approved |
0.7906 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7902 |
Intermediate Similarity |
NPD7271 |
Approved |
0.7897 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7895 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7877 |
Intermediate Similarity |
NPD5021 |
Discontinued |
0.7876 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7876 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7857 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD5100 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.7849 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD7731 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7730 |
Approved |
0.7812 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7802 |
Intermediate Similarity |
NPD482 |
Approved |
0.7798 |
Intermediate Similarity |
NPD786 |
Approved |
0.7796 |
Intermediate Similarity |
NPD3607 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.776 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD5315 |
Discontinued |
0.7751 |
Intermediate Similarity |
NPD7824 |
Approved |
0.7742 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD6026 |
Approved |
0.7727 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD5254 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7701 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD2641 |
Approved |
0.768 |
Intermediate Similarity |
NPD2640 |
Approved |
0.7665 |
Intermediate Similarity |
NPD8072 |
Approved |
0.7663 |
Intermediate Similarity |
NPD2381 |
Approved |
0.7663 |
Intermediate Similarity |
NPD2380 |
Approved |
0.7663 |
Intermediate Similarity |
NPD2382 |
Approved |
0.765 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.7642 |
Intermediate Similarity |
NPD7953 |
Approved |
0.7642 |
Intermediate Similarity |
NPD7951 |
Approved |
0.7642 |
Intermediate Similarity |
NPD7952 |
Approved |
0.7642 |
Intermediate Similarity |
NPD7950 |
Approved |
0.7642 |
Intermediate Similarity |
NPD7789 |
Approved |
0.7642 |
Intermediate Similarity |
NPD7790 |
Approved |
0.7642 |
Intermediate Similarity |
NPD7791 |
Approved |
0.7635 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.7626 |
Intermediate Similarity |
NPD8272 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7592 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7588 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.7581 |
Intermediate Similarity |
NPD8386 |
Phase 2 |
0.7579 |
Intermediate Similarity |
NPD8020 |
Approved |
0.7579 |
Intermediate Similarity |
NPD8021 |
Approved |
0.7574 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD7424 |
Clinical (unspecified phase) |
0.7565 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7565 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7563 |
Intermediate Similarity |
NPD4511 |
Phase 1 |
0.7558 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD5912 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD5913 |
Phase 3 |
0.7551 |
Intermediate Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.754 |
Intermediate Similarity |
NPD8464 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD7233 |
Approved |
0.7539 |
Intermediate Similarity |
NPD7234 |
Approved |
0.7537 |
Intermediate Similarity |
NPD8093 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD1683 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7944 |
Discontinued |
0.7526 |
Intermediate Similarity |
NPD4426 |
Clinical (unspecified phase) |
0.7525 |
Intermediate Similarity |
NPD8073 |
Approved |
0.75 |
Intermediate Similarity |
NPD4463 |
Approved |
0.75 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7487 |
Intermediate Similarity |
NPD2383 |
Phase 1 |
0.7487 |
Intermediate Similarity |
NPD5590 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD2960 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.746 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.7459 |
Intermediate Similarity |
NPD1853 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD972 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD2882 |
Phase 1 |
0.7457 |
Intermediate Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7780 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7781 |
Approved |
0.7451 |
Intermediate Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.7447 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7442 |
Intermediate Similarity |
NPD3943 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.7433 |
Intermediate Similarity |
NPD8123 |
Approved |
0.7433 |
Intermediate Similarity |
NPD8122 |
Approved |
0.7429 |
Intermediate Similarity |
NPD6148 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7426 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7414 |
Intermediate Similarity |
NPD3813 |
Approved |
0.7406 |
Intermediate Similarity |
NPD6977 |
Clinical (unspecified phase) |
0.7406 |
Intermediate Similarity |
NPD6978 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD1403 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1404 |
Approved |
0.7402 |
Intermediate Similarity |
NPD5939 |
Approved |
0.7402 |
Intermediate Similarity |
NPD5936 |
Approved |
0.7393 |
Intermediate Similarity |
NPD6976 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.7377 |
Intermediate Similarity |
NPD4550 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7374 |
Intermediate Similarity |
NPD2176 |
Approved |
0.7374 |
Intermediate Similarity |
NPD2175 |
Phase 3 |
0.7374 |
Intermediate Similarity |
NPD2177 |
Approved |
0.736 |
Intermediate Similarity |
NPD6158 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD6476 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3013 |
Phase 3 |
0.7353 |
Intermediate Similarity |
NPD3014 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD3393 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3394 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3389 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6479 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7337 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2748 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD2928 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD3583 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD8063 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.7316 |
Intermediate Similarity |
NPD8408 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD4886 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD3117 |
Approved |
0.7312 |
Intermediate Similarity |
NPD3116 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6995 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD3082 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD6999 |
Discontinued |
0.7282 |
Intermediate Similarity |
NPD4699 |
Discontinued |
0.7277 |
Intermediate Similarity |
NPD5522 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD4795 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD8026 |
Phase 1 |
0.7264 |
Intermediate Similarity |
NPD6975 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD2916 |
Discontinued |
0.7254
|
Intermediate Similarity |
NPD6217 |
Discontinued |